Navigation Links
synthesis - What's the Real Objective - Outcomes!
Date:9/11/2009

SEATTLE, Sept. 11 /PRNewswire/ -- The following blog post was published September 4, 2009, by Shafeen Charania, author of the synthesis blog, winner of the 2008 Weblog award for best new blog, and Time.com's 25 best blogs of 2009.

It's true that the devil is in the details, but if you get so focused on the details that you forget about the outcome you're trying to create, then whatever you're doing, however well the "process" worked, and however well your meetings went, you are at risk of failure.

Today healthcare is at the forefront of the American politic - but even here, the real goals are not addressed. It's not about a public option or tort reform or even budgets. The real goal has to be a healthier nation - period. None of these small issues matter if you forget about the big one! For example - the current system is more successful when more people are sick!? How does that motivate the right outcomes??

There are better approaches - to learn more, please visit: http://interacc.typepad.com/synthesis/2009/09/outcomes.htmlhttp://interacc.typepad.com/synthesis/2009/05/sorry-seems-to-be-the-hardest-word.html.

Thank you


'/>"/>
SOURCE synthesis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Trans Ionics Announces New Service - Custom Separation Synthesis (CSS)(TM)
2. Digital mammography plus digital breast tomosynthesis may decrease patient recall rates
3. Orochem Technologies Acquires Oligonet, a Custom Oligo Synthesis Business
4. Kinovate Life Sciences, Inc. and Nitto Denko Corporation Announce Successful Development of NittoPhase™ HL High Loading Solid Support for Oligonucleotide Synthesis
5. Microwave synthesis connects with the (quantum) dots
6. Thomson Reuters Adds Routes of Synthesis Data to Its Newport Horizon Premium and Newport Vision Premium Solutions
7. Synthesis of natural molecule could lead to better anti-cancer drugs
8. National Healthcare Providers Select onFocus epm(TM) To Help Ensure Success on Financial and Strategic Objectives
9. Medizone Announces That Its AsepticSure(TM) Development Program is Reaching Objectives on Two Fronts
10. Pharmos Corporation Announces Modification to Dextofisopam Trial Size, Objectives Can Still Be Achieved
11. Thomson Reuters Launches Thomson Pharma KOLexperts(R) to Help the Pharmaceutical Industry Objectively Identify, Verify and Rank Scientific Experts, Product Advocates, Clinical Investigators and Key Opinion Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Yorba Linda, Ca (PRWEB) , ... March 29, ... ... a standard process in many scientific laboratories. The assembly protocols involve many repetitive ... is well suited for automation, which enables the high-throughput needed, and results in ...
(Date:3/29/2017)... ... March 29, 2017 , ... The Wharton School of the University of Pennsylvania ... have made a $10 million gift to establish the Ken Moelis and Julie ... pathway to a Wharton MBA for highly-qualified Penn undergraduates whose academic and career interests ...
(Date:3/28/2017)... ... March 28, 2017 , ... For many women, getting birth control isn’t as easy as ... they either don’t have access to a health care facility or a pharmacy within 60 ... of the United States or for many who are faced with health or personal issues ...
(Date:3/28/2017)... ... ... The Thyroid Secret is a specialized 9-part documentary series ... recently launched on March 1, and Dr. Wentz discussed varied benefits and aspects ... Wentz is a licensed pharmacist and a foremost thyroid specialist. After being diagnosed ...
(Date:3/28/2017)... ... March 28, 2017 , ... Via Oncology, the leading provider ... a free, public-facing tool for analyzing the costs of various drug regimens in ... information to patients, providers, insurers and pharmaceutical companies about the estimated costs of ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... TAIPEI, Taiwan , March 28, 2017 /PRNewswire/ ... medical device company, is pleased to announce ... Series A investment of Panther Orthopedics, Inc., a ... pioneering innovative dynamic fixation solutions for orthopedic extremity ... market continues to expand rapidly, primarily due to ...
(Date:3/28/2017)...  "US Cancer Generics Market Outlook 2022" report ... trend analysis related to the emergence and integration ... in US. The report analyzes various clinical and ... generics drugs in recent years. The introduction of ... dollars for various stake holders involved US cancer ...
(Date:3/28/2017)... -- Orexigen Therapeutics, Inc. (Nasdaq: OREX ) today ... and year ended December 31, 2016. ... Orexigen, beginning with the re-acquisition of the rights to ... team at Orexigen demonstrated remarkable focus, executing on a ... our Company while rewarding us full control of our ...
Breaking Medicine Technology: